Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment.
about
Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IXHigh-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors.Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies.Making economic evaluations more helpful for treatment choices in haemophilia.Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).Assessing options for treating haemophilia with inhibitors.Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions.An innovative outcome-based care and procurement model of hemophilia management.How I manage patients with inherited haemophilia A and B and factor inhibitors.Factors affecting the quality, safety and marketing approval of clotting factor concentrates for haemophilia
P2860
Q33608230-B69E0301-F219-45A4-9944-A52A5C15DE6AQ37355230-41D68155-CA83-483F-86AD-B9C4C3A51A32Q38613927-38CE6253-7102-4F21-8D67-1F3C45B02EFBQ38767186-B5CE6656-218A-4FDE-A431-29003F10F90DQ40638146-357C045A-04DA-4C5E-AF0C-A10ED7D48199Q45874793-8767A1B6-B3EC-41A6-8903-5B65546FE60EQ45874959-93D38F2D-9A73-4070-9A84-C302D9A6826AQ45884983-581EEAA5-25E9-4632-A450-06A068F62AECQ48359988-72960E7B-ED70-4A58-98A4-11F547A531E3Q58701325-DED2603A-9369-4D25-A70B-918401D532C1
P2860
Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Factor VIII alloantibody inhib ...... -demand with bypass treatment.
@en
Factor VIII alloantibody inhib ...... -demand with bypass treatment.
@nl
type
label
Factor VIII alloantibody inhib ...... -demand with bypass treatment.
@en
Factor VIII alloantibody inhib ...... -demand with bypass treatment.
@nl
prefLabel
Factor VIII alloantibody inhib ...... -demand with bypass treatment.
@en
Factor VIII alloantibody inhib ...... -demand with bypass treatment.
@nl
P2093
P2860
P356
P1433
P1476
Factor VIII alloantibody inhib ...... -demand with bypass treatment.
@en
P2093
C L McDade
C M Kessler
C N Graham
J B Spears
S R Earnshaw
P2860
P304
P356
10.1111/HAE.12621
P577
2015-02-16T00:00:00Z